Physician profile
Patrick R Morris
NPI 1316937634
$1,942.36
in general payments reported to CMS, 2019-2025
12 companies · $555 in 2025
The $555 reported for 2025 was more than what 79% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $385 · 2021: $397 · 2022: $129 · 2023: $176 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564 · Entertainment: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.95 |
| Entertainment | $166.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $408.76 | 2019-2023 | Nobelactive |
| Kls-Martin L.P. | $290.78 | 2019-2022 | |
| Straumann USA LLC | $275.63 | 2019-2025 | |
| Dentsply Sirona INC | $274.00 | 2020-2025 | Astra Tech Implant System |
| Keystone Dental INC. | $166.96 | 2025 | |
| Axogen | $156.94 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $139.03 | 2023-2025 | Tmj System, Traumaone, Omnimax |
| Salvin Dental Specialties, INC. | $125.89 | 2021 | |
| Stryker Corporation | $41.74 | 2022-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System |
| Geistlich Pharma, North America, INC. | $28.34 | 2019 | |
| Dentsply Ih INC. | $19.13 | 2019 | |
| Depuy Synthes Sales INC. | $15.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.